<p>美國食品藥品監督管理局（FDA）上週對數千瓶降壓藥發出了全國召回，原因是發現與另一種藥物交叉污染。</p>
<p>聯邦監管機構於 12 月 1 日發出警告，涉及約 11,100 瓶名為 Ziac 的複合藥物比索洛爾富馬酸鹽和氫氯噻嗪。</p>
<p>檢測顯示在儲備樣本中發現了 “微量的依澤替米貝”，這是一種用於治療高膽固醇的處方藥。</p>
<p>根據該機構的説法，此次召回被歸類為三級，表明使用或接觸受污染產品 “不太可能導致不良健康後果”。</p>
<p><strong>由於標籤錯誤導致生命危險的花生過敏風險，8 個州召回 RITZ 餅乾</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>2014 年 4 月 9 日，高血壓藥片從機器中出來。（Krisztian Bocsi/Bloomberg / Getty Images）</p>
<p>總部位於新澤西州埃爾木伍德公園的 Glenmark 製藥公司生產被召回的降壓藥片和依澤替米貝。</p>
<p>聯邦監管機構表示，受影響的藥片劑量為 2.5 毫克和 6.25 毫克。</p>
<p><strong>CRAYOLA 套件因 “嚴重傷害或死亡” 風險在全國範圍內召回</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>在這張照片插圖中，Glenmark 製藥公司的標誌在智能手機屏幕上顯示。（Piotr Swat/SOPA Images/LightRocket / Getty Images）</p>
<p>FDA 補充説，此次召回涉及 30 瓶裝（NDC 68462-878-30）、100 瓶裝（NDC 68462-878-01）和 500 瓶裝（NDC 68462-878-05）。</p>
<p>被召回的批號的有效期從 2025 年 11 月到 2026 年 5 月不等，該機構表示。</p>
<p><strong>點擊此處下載福克斯新聞應用程序</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>2020 年 7 月 20 日，食品藥品監督管理局的標誌在馬里蘭州懷特奧克總部外可見。（Sarah Silbiger/Getty Images / Getty Images）</p>
<p>根據梅奧診所的説法，比索洛爾富馬酸鹽和氫氯噻嗪通常一起開處方。比索洛爾有助於心臟更規律地跳動，而氫氯噻嗪則增加排尿以去除多餘的鈉和水。兩種藥物結合有助於放鬆血管，降低血壓，並減少心臟病發作和中風的風險。</p>
<p>Glenmark 製藥和 FDA 未立即回應 FOX 商業頻道的評論請求。</p>

<p>美國食品藥品監督管理局（FDA）已對降血壓藥物 Ziac 發起全國召回，原因是與膽固醇藥物依澤替米貝（ezetimibe）發生了交叉污染。約有 11,100 瓶受到影響，劑量為 2.5mg 和 6.25mg。此次召回被分類為第三類，表明不太可能對健康造成不良後果。受影響藥物由 Glenmark Pharmaceuticals 生產。召回影響的瓶裝藥物的有效期為 2025 年 11 月至 2026 年 5 月</p>

<p>The U.S. Food and Drug Administration (FDA) issued a nationwide recall of thousands of bottles of blood-pressure medication last week after discovering cross-contamination with another drug.</p>
<div class="lb-trans"><p>美國食品藥品監督管理局（FDA）上週對數千瓶降壓藥發出了全國召回，原因是發現與另一種藥物交叉污染。</p>
</div><p>Federal regulators issued the warning on Dec. 1 for roughly 11,100 bottles of the combination medication bisoprolol fumarate and hydrochlorothiazide, sold under the brand name Ziac.</p>
<div class="lb-trans"><p>聯邦監管機構於 12 月 1 日發出警告，涉及約 11,100 瓶名為 Ziac 的複合藥物比索洛爾富馬酸鹽和氫氯噻嗪。</p>
</div><p>Testing revealed that &#34;trace amounts of ezetimibe,&#34; a prescription drug used to treat high cholesterol, were detected in reserve samples.</p>
<div class="lb-trans"><p>檢測顯示在儲備樣本中發現了 “微量的依澤替米貝”，這是一種用於治療高膽固醇的處方藥。</p>
</div><p>The recall was classified as Class III, indicating that use of or exposure to the contaminated product is &#34;not likely to cause adverse health consequences,&#34; according to the agency.</p>
<div class="lb-trans"><p>根據該機構的説法，此次召回被歸類為三級，表明使用或接觸受污染產品 “不太可能導致不良健康後果”。</p>
</div><p><strong>RITZ CRACKERS RECALLED IN 8 STATES OVER LIFE-THREATENING PEANUT ALLERGY RISK FROM MISLABELING</strong></p>
<div class="lb-trans"><p><strong>由於標籤錯誤導致生命危險的花生過敏風險，8 個州召回 RITZ 餅乾</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pills.jpg?ve=1&amp;tl=1"/></p>
<p>High blood pressure tablets exit a machine on April 9, 2014. (Krisztian Bocsi/Bloomberg / Getty Images)</p>
<div class="lb-trans"><p>2014 年 4 月 9 日，高血壓藥片從機器中出來。（Krisztian Bocsi/Bloomberg / Getty Images）</p>
</div><p>Glenmark Pharmaceuticals, based in Elmwood Park, New Jersey, manufactures both the recalled blood-pressure tablets and ezetimibe.</p>
<div class="lb-trans"><p>總部位於新澤西州埃爾木伍德公園的 Glenmark 製藥公司生產被召回的降壓藥片和依澤替米貝。</p>
</div><p>The affected pills come in 2.5-milligram and 6.25-milligram doses, according to federal regulators.</p>
<div class="lb-trans"><p>聯邦監管機構表示，受影響的藥片劑量為 2.5 毫克和 6.25 毫克。</p>
</div><p><strong>CRAYOLA KITS RECALLED NATIONWIDE OVER RISK OF 'SERIOUS INJURY OR DEATH’</strong></p>
<div class="lb-trans"><p><strong>CRAYOLA 套件因 “嚴重傷害或死亡” 風險在全國範圍內召回</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/glenmark.jpg?ve=1&amp;tl=1"/></p>
<p>In this photo illustration, the Glenmark Pharmaceuticals company logo is seen displayed on a smartphone screen. (Piotr Swat/SOPA Images/LightRocket / Getty Images)</p>
<div class="lb-trans"><p>在這張照片插圖中，Glenmark 製藥公司的標誌在智能手機屏幕上顯示。（Piotr Swat/SOPA Images/LightRocket / Getty Images）</p>
</div><p>The FDA added that the recall affects 30-count bottles (NDC 68462-878-30), 100-count bottles (NDC 68462-878-01) and 500-count bottles (NDC 68462-878-05).</p>
<div class="lb-trans"><p>FDA 補充説，此次召回涉及 30 瓶裝（NDC 68462-878-30）、100 瓶裝（NDC 68462-878-01）和 500 瓶裝（NDC 68462-878-05）。</p>
</div><p>The recalled lot numbers carry expiration dates ranging from November 2025 to May 2026, the agency said.</p>
<div class="lb-trans"><p>被召回的批號的有效期從 2025 年 11 月到 2026 年 5 月不等，該機構表示。</p>
</div><p><strong>CLICK HERE TO DOWNLOAD THE FOX NEWS APP</strong></p>
<div class="lb-trans"><p><strong>點擊此處下載福克斯新聞應用程序</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/08/931/523/fda-hq.jpg?ve=1&amp;tl=1"/></p>
<p>A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland. (Sarah Silbiger/Getty Images / Getty Images)</p>
<div class="lb-trans"><p>2020 年 7 月 20 日，食品藥品監督管理局的標誌在馬里蘭州懷特奧克總部外可見。（Sarah Silbiger/Getty Images / Getty Images）</p>
</div><p>Bisoprolol fumarate and hydrochlorothiazide are commonly prescribed together, according to Mayo Clinic. Bisoprolol helps the heart beat more regularly, while hydrochlorothiazide increases urination to remove excess sodium and water. Combined, the drugs help relax blood vessels, lower blood pressure, and reduce the risk of heart attacks and strokes.</p>
<div class="lb-trans"><p>根據梅奧診所的説法，比索洛爾富馬酸鹽和氫氯噻嗪通常一起開處方。比索洛爾有助於心臟更規律地跳動，而氫氯噻嗪則增加排尿以去除多餘的鈉和水。兩種藥物結合有助於放鬆血管，降低血壓，並減少心臟病發作和中風的風險。</p>
</div><p>Glenmark Pharmaceuticals and the FDA did not immediately respond to a request for comment from FOX Business.</p>
<div class="lb-trans"><p>Glenmark 製藥和 FDA 未立即回應 FOX 商業頻道的評論請求。</p>
</div>

血壓藥物在全國範圍內被召回，FDA 發現了意外的藥物混合